Intraoperative transfusion management, antifibrinolytic therapy, coagulation monitoring and the impact on short-term outcomes after liver transplantation-A systematic review of the literature and expert panel recommendations.
GRADE approach
blood transfusion
cell salvage
coagulation factors
cryoprecipitate
fresh frozen plasma
liver transplantation
packed red blood cells
platelet
rotational thromboelastometry
thromboelastography
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
11
01
2022
accepted:
28
02
2022
pubmed:
7
3
2022
medline:
15
12
2022
entrez:
6
3
2022
Statut:
ppublish
Résumé
Liver transplantation (LT) is frequently complicated by coagulopathy associated with end-stage liver disease (ESLD), that is, often multifactorial. The objective of this systematic review was to identify evidence based intraoperative transfusion and coagulation management strategies that improve immediate and short-term outcomes after LT. PRISMA-guidelines and GRADE-approach were followed. Three subquestions were formulated. (Q); Q1: transfusion management; Q2: antifibrinolytic therapy; and Q3: coagulation monitoring. Sixteen studies were included for Q1, six for Q2, and 10 for Q3. Q1: PRBC and platelet transfusions were associated with higher mortality. The use of prothrombin complex concentrate (PCC) and fibrinogen concentrate (FC) were not associated with reductions in intraoperative transfusion or increased thrombotic events. The use of cell salvage was not associated with hepatocellular carcinoma (HCC) recurrence or mortality. Cell salvage and transfusion education significantly decreased blood product transfusions. Q2: Epsilon-aminocaproic acid (EACA) and tranexamic acid (TXA) were not associated with decreased blood product transfusion, improvements in patient or graft survival, or increases in thrombotic events. Q3: Viscoelastic testing (VET) was associated with decreased allogeneic blood product transfusion compared to conventional coagulation tests (CCT) and is likely to be cost-effective. Coagulation management guided by VET may be associated with increases in FC and PCC use. Q1: A specific blood product transfusion practice is not recommended (QOE; low | Recommendation; weak). Cell salvage and educational interventions are recommended (QOE: low | Grade of Recommendation: moderate). Q2: The routine use of antifibrinolytics is not recommended (QOE; low | Recommendation; weak). Q3: The use of VET is recommended (QOE; low-moderate | Recommendation; strong).
Sections du résumé
BACKGROUND
Liver transplantation (LT) is frequently complicated by coagulopathy associated with end-stage liver disease (ESLD), that is, often multifactorial.
OBJECTIVES
The objective of this systematic review was to identify evidence based intraoperative transfusion and coagulation management strategies that improve immediate and short-term outcomes after LT.
METHODS
PRISMA-guidelines and GRADE-approach were followed. Three subquestions were formulated. (Q); Q1: transfusion management; Q2: antifibrinolytic therapy; and Q3: coagulation monitoring.
RESULTS
Sixteen studies were included for Q1, six for Q2, and 10 for Q3. Q1: PRBC and platelet transfusions were associated with higher mortality. The use of prothrombin complex concentrate (PCC) and fibrinogen concentrate (FC) were not associated with reductions in intraoperative transfusion or increased thrombotic events. The use of cell salvage was not associated with hepatocellular carcinoma (HCC) recurrence or mortality. Cell salvage and transfusion education significantly decreased blood product transfusions. Q2: Epsilon-aminocaproic acid (EACA) and tranexamic acid (TXA) were not associated with decreased blood product transfusion, improvements in patient or graft survival, or increases in thrombotic events. Q3: Viscoelastic testing (VET) was associated with decreased allogeneic blood product transfusion compared to conventional coagulation tests (CCT) and is likely to be cost-effective. Coagulation management guided by VET may be associated with increases in FC and PCC use.
CONCLUSION
Q1: A specific blood product transfusion practice is not recommended (QOE; low | Recommendation; weak). Cell salvage and educational interventions are recommended (QOE: low | Grade of Recommendation: moderate). Q2: The routine use of antifibrinolytics is not recommended (QOE; low | Recommendation; weak). Q3: The use of VET is recommended (QOE; low-moderate | Recommendation; strong).
Substances chimiques
Antifibrinolytic Agents
0
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14637Investigateurs
Mohammad Alradhawi
(M)
Lorenzo Lenti
(L)
Claus Niemann
(C)
Joerg-Matthias Pollok
(JM)
Marina Berenguer
(M)
Pascale Tinguely
(P)
Informations de copyright
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Kang Y, Audu P. Coagulation and liver transplantation. Int Anesthesiol Clin. 2006;44(4):17-36.
Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The coagulation profile of end-stage liver disease and considerations for intraoperative management. Anesth Analg. 2018;126(1):46-61.
Biancofiore G, Blasi A, De Boer MT, et al. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE). Minerva Anestesiol. 2019;85(7):782-798.
Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol. 2014;20(20):6146.
Kang Y. Coagulation and liver transplantation: current concepts. Liver Transplant Surg. 1997;3(4):465-467.
Bezinover D, Dirkmann D, Findlay J, et al. Perioperative coagulation management in liver transplant recipients. Transplantation. 2018;102(4):578-592.
Buliarca A, Horhat A, Mocan T, Craciun R, Procopet B, Sparchez Z. Viscoelastic tests in liver disease: where do we stand now? World J Gastroenterol. 2021;27(23):3290-3302.
Wei H, Child LJ. Clinical utility of viscoelastic testing in chronic liver disease: a systematic review. World J Hepatol. 2020;12(11):1115-1127.
Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg. 1985;64(9):888-896.
Whiting P, Al M, Westwood M, et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(58):1-228.
Dias BH, Rana AAM, Olakkengil SA, et al. Development and implementation of an enhanced recovery after surgery protocol for renal transplantation. ANZ J Surg. 2019;89(10):1319-1323.
Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.
Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85.
Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719-725.
Andrews JC, Schünemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol. 2013;66(7):726-735.
Jóźwik A, Karpeta E, Nita M, Łągiewska B, Pacholczyk M. Impact of blood loss and intraoperative blood transfusion during liver transplantation on the incidence of early biliary complications and mortality. Transplant Proc. 2020;52(8):2477-2479.
Rana A, Petrowsky H, Hong JC, et al. Blood transfusion requirement during liver transplantation is an important risk factor for mortality. J Am Coll Surg. 2013;216(5):902-907.
Real C, Sobreira Fernandes D, Sá Couto P, et al. Survival predictors in liver transplantation: time-varying effect of red blood cell transfusion. Transplant Proc. 2016;48(10):3303-3306.
Goldaracena N, Méndez P, Quiñonez E, et al. Liver transplantation without perioperative transfusions single-center experience showing better early outcome and shorter hospital stay. J Transplant. 2013;2013:1-7.
Fayed NA, Abdallah AR, Khalil MK, Marwan IK. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets. 2014;25(8):576-586.
Colavecchia AC, Cohen DA, Harris JE, et al. Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation. Transfusion. 2017;57(12):3026-3034.
Akbulut S, Kayaalp C, Yilmaz M, et al. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol. 2013;19(10):1625.
Ozkardesler S, Avkan-Oguz V, Akan M, et al. Effects of blood products on nosocomial infections in liver transplant recipients. Exp Clin Transplant. 2013;11(6):530-536.
Hartmann M, Walde C, Dirkmann D, Saner FH. Safety of coagulation factor concentrates guided by ROTEM™-analyses in liver transplantation: results from 372 procedures. BMC Anesthesiol. 2019;19(1). https://doi.org/10.1186/S12871-019-0767-X.
Chin JL, Hisamuddin SH, O'Sullivan A, Chan G, McCormick PA. Thrombocytopenia, platelet transfusion, and outcome following liver transplantation. Clin Appl Thromb Hemost. 2016;22(4):351-360.
Ho YC, Inn K, Fook L, Lai O. Impact of incorporation of fibrinogen concentrate in blood transfusion management during liver transplantation: an early local (single centre) experience. Int J Clin Transfus Med. 2020;8:1-5.
Araujo RL, Pantanali CA, Haddad L, Filho JAR, D'Albuquerque LAC, Andraus W. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg. 2016;8(2):161.
Hogen R, Dhanireddy K, Clark D, et al. Balanced blood product transfusion during liver transplantation. Clin Transplant. 2018;32(3):e13191.
Pagano MB, Metcalf RA, Hess JR, Reyes J, Perkins JD, Montenovo MI. A high plasma: red blood cell transfusion ratio during liver transplantation is associated with decreased blood utilization. Vox Sang. 2018;113(3):268-274.
Nedelcu E, Wright MF, Karp S, Cook M, Barbu O, Eichbaum Q. Quality improvement in transfusion practice of orthotopic liver transplantation reduces blood utilization, length of hospital stay, and cost. Am J Clin Pathol. 2019;151(4):395.
Mangus RS, Kinsella SB, Fridell JA, et al. Aminocaproic acid (Amicar) as an alternative to aprotinin (Trasylol) in liver transplantation. Transplant Proc. 2014;46(5):1393-1399.
Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Roy A. Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Transplantation. 2011;91(11):1273-1278.
Nicolau-Raducu R, Ku TC, Ganier DR, et al. Epsilon-Aminocaproic acid has no association with thromboembolic complications, renal failure, or mortality after liver transplantation. J Cardiothorac Vasc Anesth. 2016;30(4):917-923.
Schofield N, Sugavanam A, Thompson K, Mallett SV. No increase in blood transfusions during liver transplantation since the withdrawal of aprotinin. Liver Transpl. 2014;20(5):584-590.
Trzebicki J, Kosieradzki M, Flakiewicz E, et al. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience. Transplant Proc. 2011;43(5):1725-1727.
Badenoch A, Sharma A, Gower S, et al. The effectiveness and safety of tranexamic acid in orthotopic liver transplantation clinical practice: a propensity score matched cohort study. Transplantation. 2017;101(7):1658-1665.
Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319-2331.
Rothermel LD, Lipman JM. Estimation of blood loss is inaccurate and unreliable. Surgery. 2016;160(4):946-953.
Leon-Justel A, Noval-Padillo JA, Alvarez-Rios AI, et al. Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome. Clin Chim Acta. 2015;446:277-283.
Leon-Justel A, Alvarez-Rios AI, Noval-Padillo JA, et al. Point-of-care haemostasis monitoring during liver transplantation is cost effective. Clin Chem Lab Med. 2019;57(6):883-890.
Schumacher C, Eismann H, Sieg L, et al. Use of rotational thromboelastometry in liver transplantation is associated with reduced transfusion requirements. Exp Clin Transplant. 2019;17(2):222-230.
Smart L, Mumtaz K, Scharpf D, et al. Rotational thromboelastometry or conventional coagulation tests in liver transplantation: comparing blood loss, transfusions, and cost. Ann Hepatol. 2017;16(6):916-923.
Bonnet A, Gilquin N, Steer N, et al. The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: a randomised controlled study. Eur J Anaesthesiol. 2019;36(11):825-833.
Roullet S, Freyburger G, Cruc M, et al. Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry-based algorithm. Liver Transpl. 2015;21(2):169-179.
Wang SC, Shieh JF, Chang KY, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010;42(7):2590-2593.
Zamper RPC, Amorim TC, Queiroz VNF, et al. Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study. BMC Anesthesiol. 2018;18(1):198.
Nascimento JCR, Neto EBL, da Silva EL, et al. Analysis of the hemostatic therapy in liver transplantation guided by rotational thromboelastometry or conventional laboratory tests. Eur J Gastroenterol Hepatol. 2020;32(11):1452-1457.
Schumann R, Mandell MS, Mercaldo N, et al. Anesthesia for liver transplantation in United States academic centers: intraoperative practice. J Clin Anesth. 2013;25(7):542-550.
Álamo JM, León A, Mellado P, et al. Is “intra-operating room” thromboelastometry useful in liver transplantation? A case-control study in 303 patients. Transplant Proc. 2013;45(10):3637-3639.
Callum JDW. No Title. Transfusion Therapy: Clinical Principles and Practice. 3rd ed. AABB Press; 2011:1-35.
Yoon U, Lai M, Nguyen T, Elia E. Perioperative viscoelastic assay use for monitoring coagulation among US liver transplantation centers. Transplant Proc. 2021;53(7):2312-2317.
Sakai T. Viscoelastic testing in liver transplantation. Transfusion. 2020;60(S6):S61-S69.